☰

Joyonna Gamble-George, Ph.D. - Publications

Affiliations: 
2007-2009 VA Bay Pines Healthcare System 
 2007-2009 University of South Florida, Tampa, FL, United States 
 2009-2011 Meharry Medical College, Nashville, TN, United States 
 2011-2016 Vanderbilt University, Nashville, TN 
 2016-2018 University of Florida College of Medicine/McKnight Brain Institute 
 2019-2021 National Institutes of Health, Bethesda, MD 
Website:
https://www.joyonnagamble.com/
Tree Info Grants Similar researchers Related pubs Distance to... Nearest Nobel PubMed Report error

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Gamble-George JC, Longenecker CT, Webel AR, Au DH, Brown AF, Bosworth H, Crothers K, Cunningham WE, Fiscella KA, Hamilton AB, Helfrich CD, Ladapo JA, Luque A, Tobin JN, Wyatt GE; Implementation Research to Develop Interventions for People Living with HIV (PRECluDE) Consortium. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): Combatting chronic disease comorbidities in HIV populations through implementation research. Progress in Cardiovascular Diseases. 63: 79-91. PMID 32199901 DOI: https://doi.org/10.1016/j.pcad.2020.03.006  0.01
2018 Miller DR, Shaerzadeh F, Phan L, Sharif N, Gamble-George J, McLaughlin JP, Streit WJ, Khoshbouei H. HIV-1 Tat regulation of dopamine transmission and microglial reactivity is brain region specific. Glia. PMID 29733459 DOI: 10.1002/glia.23447  1
2017 Gaskill PJ, Miller DR, Gamble-George J, Yano H, Khoshbouei H. HIV, Tat and dopamine transmission. Neurobiology of Disease. 105: 51-73. PMID 28457951 DOI: https://doi.org/10.1016/j.nbd.2017.04.015  1
2016 Gamble-George JC, Baldi R, Halladay L, Kocharian A, Hartley N, Silva CG, Roberts H, Haymer A, Marnett LJ, Holmes A, Patel S. Cyclooxygenase-2 inhibition reduces stress-induced affective pathology. Elife. 5. PMID 27162170 DOI: 10.7554/eLife.14137  1
2014 Butler B, Gamble-George J, Prins P, North A, Clarke JT, Khoshbouei H. Chronic Methamphetamine Increases Alpha-Synuclein Protein Levels in the Striatum and Hippocampus but not in the Cortex of Juvenile Mice. Journal of Addiction & Prevention. 2. PMID 25621291  1
2014 Bluett RJ, Gamble-George JC, Hermanson DJ, Hartley ND, Marnett LJ, Patel S. Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation. Translational Psychiatry. 4: e408. PMID 25004388 DOI: 10.1038/tp.2014.53  1
2014 Hermanson DJ, Gamble-George JC, Marnett LJ, Patel S. Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation. Trends in Pharmacological Sciences. 35: 358-67. PMID 24845457 DOI: 10.1016/j.tips.2014.04.006  1
2014 Ramikie TS, Nyilas R, Bluett RJ, Gamble-George JC, Hartley ND, Mackie K, Watanabe M, Katona I, Patel S. Multiple mechanistically distinct modes of endocannabinoid mobilization at central amygdala glutamatergic synapses. Neuron. 81: 1111-25. PMID 24607231 DOI: 10.1016/j.neuron.2014.01.012  1
2013 Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, Colbran RJ, Reese J, Marnett LJ, Patel S. Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nature Neuroscience. 16: 1291-8. PMID 23912944 DOI: 10.1038/nn.3480  1
2013 Gamble-George JC, Conger JR, Hartley ND, Gupta P, Sumislawski JJ, Patel S. Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice. Psychopharmacology. 228: 401-9. PMID 23483200 DOI: 10.1007/s00213-013-3042-8  1
2013 North A, Swant J, Salvatore MF, Gamble-George J, Prins P, Butler B, Mittal MK, Heltsley R, Clark JT, Khoshbouei H. Chronic methamphetamine exposure produces a delayed, long-lasting memory deficit. Synapse (New York, N.Y.). 67: 245-57. PMID 23280858 DOI: 10.1002/syn.21635  1
2013 Gunduz-Cinar O, MacPherson KP, Cinar R, Gamble-George J, Sugden K, Williams B, Godlewski G, Ramikie TS, Gorka AX, Alapafuja SO, Nikas SP, Makriyannis A, Poulton R, Patel S, Hariri AR, et al. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry. 18: 813-23. PMID 22688188 DOI: 10.1038/mp.2012.72  1
2011 Swant J, Goodwin JS, North A, Ali AA, Gamble-George J, Chirwa S, Khoshbouei H. α-Synuclein stimulates a dopamine transporter-dependent chloride current and modulates the activity of the transporter. The Journal of Biological Chemistry. 286: 43933-43. PMID 21990355 DOI: 10.1074/jbc.M111.241232  1
2009 Echeverria V, Burgess S, Gamble-George J, Zeitlin R, Lin X, Cao C, Arendash GW. Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice. Neuroscience. 162: 1220-31. PMID 19447162 DOI: 10.1016/j.neuroscience.2009.05.019  1
2008 Echeverria V, Burgess S, Gamble-George J, Arendash GW, Citron BA. Raf inhibition protects cortical cells against beta-amyloid toxicity. Neuroscience Letters. 444: 92-6. PMID 18706973 DOI: 10.1016/j.neulet.2008.07.092  1
Show low-probability matches.